Topic

Articles

US and Chinese pharmacopeial standards groups commit to collaboration on standards for drug safety.

USP and Chinese Pharmacopeia Extend Partnership

Michael Kuchenreuther, PhD, is a research analyst, at Numerof & Associates, Inc.

Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.

The Evolving War on Drug Prices

Roger Humphrey is executive managing director of JLL Life Sciences.

Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.

Emerging Life-Sciences Markets: New Partnerships, New Competitors

The author provides an overview of the key aspects of the current Canadian pharmaceutical market.

Market Access Outlook for Canada

Cambridge Consultants engaged in a workshop-style dialogue with a cross section of senior personnel from both Indian and multinational pharma companies to debate whether emerging markets are an opportunity to drive sustainable growth. Conclusions from the workshop are presented in this article.

Emerging Markets—An Opportunity for Pharma to Drive Sustainable Growth

The excipient supplier's cGMP practices have been certified as meeting EXCiPACT standards

Boai NKY Pharmaceuticals becomes first Chinese supplier to get EXCiPACT certification

China’s emergence as a significant commercial market is forcing manufacturers to re-evaluate their overall business model.

Market Access in China

With the Indian pharmaceutical industry on the rise, manufacturing businesses are working together with European and American partners to harness their longstanding experience and reputation in cleanroom manufacturing for a broader pharmaceutical manufacturing marketplace.

Breaking Down Pharma Borders

Jane Wan is a freelance writer based in Singapore.

Hope abounds for local drug discovery companies despite challenges at home.

Drug Discovery and Development in India

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.

Global Perspectives